Skip to main content

LCD L38201: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)

LCD L38201, Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF), is the Local Coverage Determination that CGS Administrators, LLC applies to claims from 2 states (KY, OH), effective 2025-11-20 and first in force 2019-11-18. The policy text runs 278 words, and its billing and coding article A57282 lists 8 ICD-10-CM codes that support medical necessity for 6 procedure codes. 4 other contractors publish a policy with the same title, so the criteria that apply depend on where the service is furnished.

QuickIntell editorial content · Legacy registry date · Review not verified

Data effective
Data currency: Medicare Coverage Database LCD export release of September 24, 2026 (effective September 20, 2026). Next CMS release: weekly (Thursdays) for the MCD.
Contractor
CGS Administrators, LLC
States and territories
2
KY OH
Revision effective
2025-11-20
Original effective
2019-11-18
Policy text
278 words
Covered ICD-10 codes (articles)
8

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L38201
ContractContractorTypeStates
15102CGS Administrators, LLCMAC - Part BKY
15202CGS Administrators, LLCMAC - Part BOH
15101CGS Administrators, LLCMAC - Part AKY
15201CGS Administrators, LLCMAC - Part AOH

Billing and coding: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A57282 (Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown.

A57282: Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) (Billing and Coding, effective 2025-10-08)

Covered ICD-10-CM codes
8
2 groups
Non-covered ICD-10-CM codes
0
Procedure codes listed
6
Full article
cms.gov record
First 8 covered ICD-10-CM codes in A57282
ICD-10-CMDescription (FY2027)
C41.2—
C79.51—
C90.00—
C90.02—
M80.08XA—
M80.88XA—
M84.58XA—
M84.58XS—

Procedure codes: 22510, 22511, 22512, 22513, 22514, 22515.

Coverage indications, limitations and medical necessity

PVA (percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP)) is covered in patients who qualify based on the following criteria:

1. Inclusion criteria ( ALL are required ):

• Acute ( 1-3,10,25,27

• Symptomatic ( ONE ):

• Hospitalized with severe pain (Numeric Rating Scale (NRS) or Visual Analog Scale (VAS) pain score ≥8) 4-7

• Non-hospitalized with moderate-to-severe pain (NRS or VAS ≥5) despite optimal non-surgical management (NSM) 10 * ( ONE ):

• Worsening pain

• Stable-to-improved pain (but NRS or VAS still ≥5) ( with ≥ 2 of the following ):

• Progression of vertebral body height loss

• >25% vertebral body height reduction

• Kyphotic deformity

• Severe impact of VCF on daily functioning (Roland Morris Disability Questionnaire (RDQ) >17)

*Consider including pedicle periosteal infiltration 7

c. Continuum of care 10 (BOTH) :

• All patients presenting with VCF should be referred for evaluation of bone mineral density (BMD) and osteoporosis education for subsequent treatment as indicated.

• All patients with VCF should be instructed to take part in an osteoporosis prevention/treatment program.

2. Exclusion criteria 2,5,8-10 :

a. Absolute contraindication:

• Current back pain is not primarily due to the identified acute or subacute VCF(s)

• Osteomyelitis, discitis or active systemic or surgical site infection

• Pregnancy

b. Relative contraindication:

• Allergy to bone cement or opacification agents

• Uncorrected coagulopathy

• Spinal instability

• Myelopathy from the fracture

• Neurologic deficit

• Neural impingement

• Fracture retropulsion/canal compromise

• Greater than 3 vertebral fractures

Vertebral augmentation and kyphoplasty for VCFs with intractable spinal pain not relieved with medical therapy will be covered for osteolytic vertebral metastatic disease or myeloma involving a vertebral body.

Summary of evidence (opening)

Osteoporotic Compression Fractures

Osteoporosis (and low bone mass) affects 50 percent of people over 50 years of age, or over 50 million people in the United States. Its primary impact, fractures (also called fragility or low-trauma fractures), occurs secondary to normal activity (e.g., bending, coughing, lifting, fall from a standing height), and eventually occurs in 50% of women and 20% of men. VCFs constitute one-quarter of osteoporotic fractures (6), often at the midthoracic (T7-T8) and thoracolumbar junction (T12-L1). They may cause significant acute and chronic pain, leading to complications of impaired mobility comparable to a hip fracture (pneumonia, loss of bone and muscle mass, incidental falls, deep venous thrombosis, depression, and isolation) (10). Medicare claims data shows a 85% 10 year mortality following a VCF diagnosis (11). Under-diagnosis and under-treatment may exacerbate morbidity and mortality (10).

Treatment options for symptomatic osteoporotic VCF range from NSM (anti-osteoporosis therapy, analgesics, limited activity/bed rest, back brace, physical therapy) to PVA (PVP and PKP). PVP involves the percutaneous injection of bone cement under image guidance into the VCF. PKP adds balloon tamponade within the fractured vertebral body to create a low-pressure cavity prior to cement injection. Both treatments aimed to immobilize the fracture, reduce pain, and improve alignment.

Successful small European series introduced PVP into the United States in 1993; by 2007 encouraging preliminary observational data led to medical society endorsement and clinical acceptance in painful osteoporotic VCFs refractory to medical management. Subsequent early open-label randomized controlled trials (RCTs), including the Vertebroplasty for Painful Chronic Osteoporotic Vertebral Fractures (VERTOS) trial (21), the Fracture Reduction Evaluation (FREE) trial (22, 23), VERTOS II (14), and others, found a benefit of vertebral augmentation over non-surgical management.

The contractor cites 38 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2019-11-18
Current revision effective
2025-11-20
Last reviewed by the contractor
2025-11-05
MCD version
25

Other related documents: A58462 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line, and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the CGS Administrators, LLC hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

Frequently asked questions

What does LCD L38201 cover?

PVA (percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP)) is covered in patients who qualify based on the following criteria: The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database export of September 24, 2026.

Which states does LCD L38201 apply to?

CGS Administrators, LLC applies it to Medicare claims in KY, OH. A Local Coverage Determination binds only the contractor that wrote it; the same service in another jurisdiction is judged under that contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L38201?

The companion billing and coding article A57282 lists 8 ICD-10-CM codes in 2 groups that support medical necessity; the first 8 appear on this page and the complete list is in the article on cms.gov.

How do I appeal a denial under LCD L38201?

The remittance carries claim adjustment reason code 50 with remark code N115, naming the LCD. Compare the documented indication with the policy's covered indications and the article's diagnosis list, then file a redetermination within 120 days with the record attached; if the service genuinely falls outside the policy, the patient can be billed only when a valid Advance Beneficiary Notice was obtained before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.